CSL #FlashbackFriday 2016-2021(Part 1): 2017, CSL acquires a majority stake in Chinese plasma fractionator, Ruide,… https://t.co/MmmpH6fPHa
CSL #FlashbackFriday 2016-2021 (Part 3): With COVID-19 gripping the world, CSL partners with University of Queensla… https://t.co/XrDBpYZqb2
CSL #FlashbackFriday 2016-2021 (Part 2): 2019, CSL celebrates 25 years on the ASX and announces the development of… https://t.co/9Yx5LNfMg9
Exciting opportunity from the @RoyalSocietyVic for young scientists in the areas of Biomedical & Health Sciences, B… https://t.co/WnoqfdVnnd
"I’m heartened by the continued collaboration our industry has demonstrated and I think I can speak for everyone in… https://t.co/YAkRXjN7RK
Tricia Stewart, Senior Vice President and General Manager, CSL Behring Australia, shares how the Broadmeadows site… https://t.co/Jr1nsF7XhU
At #CSL, we work for patients and public health 365 days a year, but #RareDiseaseDay is an especially good time to… https://t.co/uMg57UpeiH
“Right now, our purpose – the reason we exist – has never been clearer than during this public health crisis.” Paul… https://t.co/4YUdCYDTjK
Announcing CSL’s HY Results today, CEO and MD, Mr Paul Perreault said, “Our people and business model both demonstr… https://t.co/hiV8Q5vT1Y
An exciting week for the Seqirus Parkville team, with the start of filling the first vials of the AstraZeneca COVID… https://t.co/igIJXpROAP